A member of the family of echinocandins that inhibits 1,3-β-D-glucan synthase. It is developed by Cidara Therapeutics and approved for the treatment of candidaemia and invasive candidiasis in patients aged ≥ 18 years who have limited or no alternative treatment options.
Stars
This entity has been manually annotated by the ChEBI Team.